Teva Pharmaceutical (TEVA) revised its financial forecast after low third-quarter sales
Teva Pharmaceutical (TEVA) announced its financial results on Thursday reporting low third-quarter sales and the company reduce its full-year revenue figures. Teva reported 58 cents per share income for the quarter ended September 30, 2020, which is in line with the analyst’s estimates. The earing remains flat over the year. The company sales declined by 2.8% […]
